![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real world outcomes from NS5a treatment failures undergoing therapy with
sofosbuvir/velpatasvir/voxilaprevir and sofosbuvir/glecaprevir/pibrentasvir
|
|
|
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
A. BOYLE1,2, F. MARRA1,2, R. FOX1, E. PETERS1, E. THOMSON1,3, R. GUNSON4, A BRADLEY4, S.T. BARCLAY5
1 Gartnavel General Hospital, Glasgow. 2 University of Liverpool, Liverpool. 3MRC-University of Glasgow Centre for Virus Research 4 West of
Scotland Specialist Virology Centre 5 Glasgow Royal Infirmary, Glasgow. United Kingdom
![0411191](../images/041119/041119-8/0411191.gif)
![0411192](../images/041119/041119-8/0411192.gif)
![0411193](../images/041119/041119-8/0411193.gif)
![0411194](../images/041119/041119-8/0411194.gif)
![0411195](../images/041119/041119-8/0411195.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|